Healthy Clinical Trial
— FAARMOfficial title:
Farms, Animals and Adolescents: Reinforcing the Microbiome
Verified date | October 2017 |
Source | University of Wisconsin, Madison |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will be an observational study of children who attend summer camp at the Heartland Farm Sanctuary (HFS). The investigators are exploring whether time-limited exposure to a traditional farming environment will improve children's overall health and general well-being.
Status | Completed |
Enrollment | 11 |
Est. completion date | September 30, 2017 |
Est. primary completion date | September 30, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 7 Years to 13 Years |
Eligibility |
Inclusion Criteria for Children: - Males and females ages 7-13 years - Able to attend camp at Heartland Farm Sanctuary for either 1, 2, or 3 consecutive weeks (if not consecutive, but within a 4-week period, this is allowable) - In generally good health - Have not taken antibiotics in the four weeks prior to when their first baseline set of samples will be collected - Have not attended camp at HFS or regular volunteer activities at HFS in the past year (participation in previous summer HFS camp is permissible) - Able to understand the nature of the study and able to provide assent - Able to communicate in English with study personnel. - Willing to commit to participating in the study and doing the home collection of samples. Exclusion Criteria for Children: - Individuals who will not be able to collect the samples for any reason, including planned vacations, unwillingness, or inability. (Note - children who are attending either 2 or 3 weeks of camp and who take a break in between weeks of camp will be allowed to participate if their full two or three-week camp exposure occurs within a 4-week period). - Plan to attend camp during the fall (i.e. during their month 1 month follow-up) - Children living in farming environments prior to camp participation - Children with more than an average of one exposure per week to farm animals, livestock, horses - Individuals currently on any antibiotic therapy or who will require chronic and/or periodic antibiotic treatment during the study period. - Subject has a medical condition or disorder that - Is unstable, or: - Could interfere with the accurate assessment of safety or efficacy of the clinical assessments, including individuals with any: - Current participation in any clinical trial that might impact results of this one, which includes participation in another clinical trial where any experimental drugs are being taken as well as studies / drug trials with agents that might affect mood and or the gastrointestinal tract. - Reasonable likelihood for non-compliance with the protocol for any other reason, in the opinion of the Investigator, prohibits enrollment of subject into the study. Inclusion Criteria for Parents/Guardians: - Parent or legal guardian of a child attending HFS summer camp and participating in this study - Willing to assist the child in the collection of samples as necessary - Willing to answer questionnaire about their child's participation in the study - Able to communicate in English with study personnel Exclusion Criteria for Parents/Guardians: - Unwilling to assist their child in collection of the samples for this study - Unwilling to answer questionnaire about their child's participation in the study - Unable to communicate in English with study personnel |
Country | Name | City | State |
---|---|---|---|
United States | University of Wisconsin-Madison | Madison | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
University of Wisconsin, Madison |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in microbiota alpha diversity from baseline to immediately post-camp. | Immediately post-camp | ||
Primary | Change in microbiota beta diversity from baseline to immediately post-camp. | Immediately post-camp | ||
Primary | Change in the mean scores in the WHO-5 from baseline to immediately post camp. | Immediately post camp | ||
Primary | Change in the mean scores in the EmQue-CA from baseline to immediately post camp. | Immediately post camp | ||
Primary | Change in the mean scores in the PSC-35 from baseline to immediately post camp. | Immediately post camp | ||
Primary | Change in the mean scores in the Youth PSC from baseline to immediately post camp. | Immediately post camp | ||
Secondary | Change in microbiota alpha diversity from baseline to month 1. | 1 month post-camp | ||
Secondary | Change in microbiota beta diversity from baseline to month 1. | 1 month post-camp | ||
Secondary | Change in the mean scores in the WHO-5 from baseline to month 1. | 1 month post-camp | ||
Secondary | Change in the mean scores in the EmQue-CA from baseline to month 1. | 1 month post-camp | ||
Secondary | Change in the mean scores in the PSC-35 from baseline to month 1. | 1 month post-camp | ||
Secondary | Change in the mean scores in the Youth PSC from baseline to month 1. | 1 month post-camp |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |